Bleeding risk in hemodialysis patients
AE van der Sluijs, P Pai, W Zhu, G Ocak - Seminars in Nephrology, 2024 - Elsevier
Cardiovascular diseases are highly prevalent among patients on dialysis. For these
diseases, antiplatelets and antithrombotic therapies including heparin, vitamin K …
diseases, antiplatelets and antithrombotic therapies including heparin, vitamin K …
Addressing Undertreatment of Atrial Fibrillation With Community Pharmacists
AL Allen, GD Barnes - JAMA Network Open, 2024 - jamanetwork.com
Atrial fibrillation (AF) increases the likelihood of ischemic strokes, including those most likely
to result in death or permanent disability. This combined with the growing number of patients …
to result in death or permanent disability. This combined with the growing number of patients …
Contemporary trends in incident ischemic stroke, intracranial hemorrhage, and mortality in individuals with atrial fibrillation
JJ Noubiap, JJ Tang, TA Dewland… - … Heart Journal-Quality …, 2024 - academic.oup.com
Background The prognosis for atrial fibrillation (AF) patients is based on data that is decades
old. Given evolving standards of clinical practice, we sought to evaluate temporal trends in …
old. Given evolving standards of clinical practice, we sought to evaluate temporal trends in …
Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
AT Kefale, WM Bezabhe, GM Peterson - Journal of Clinical Medicine, 2023 - mdpi.com
Background: The use of oral anticoagulants (OACs) in patients with atrial fibrillation (AF) and
low stroke risk might cause more harm than benefit. Little attention has been given to …
low stroke risk might cause more harm than benefit. Little attention has been given to …
Phenotypes and outcomes in non-anticoagulated patients with atrial fibrillation: An unsupervised cluster analysis
Background Patients with atrial fibrillation are characterized by great clinical heterogeneity
and complexity. The usual classifications may not adequately characterize this population …
and complexity. The usual classifications may not adequately characterize this population …
[PDF][PDF] Antithrombotic therap in the Netherlands: ne insights from nation ide data
Q Chen - Thromb Haemost, 2022 - scholarlypublications …
[5] Toorop MMA, Chen Q, Kruip M, van der Meer FJM, Nierman MC, Faber L, et al. Switching
from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation …
from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation …